Overview: Ureaplasma urealyticum TestIntroduction: The Ureaplasma urealyticum Test detects Ureaplasma urealyticum, a bacteria causing genital or urinary infections, helping guide treatment for discomfort or infertility. Affecting 1 in 100 sexually active individuals, U. urealyticum poses diagnostic challenges due to asymptomatic cases. Following 2023 Centers for Disease Control and Prevention (CDC) guidelines, it uses culture/PCR for high accuracy, supporting bacteriology screening. This test is essential for diagnosis, treatment planning, and improving outcomes in urology.
Other Names: U. urealyticum Detection Test, Genital Infection Assay.
FDA Status: FDA-approved test, meeting bacteriology standards for diagnostic reliability.
Historical Milestone: Ureaplasma testing began in the 1950s with research by Shepard, who identified the bacteria. PCR advancements by Roche improved detection, surpassing earlier culture methods.
Purpose: Detects U. urealyticum presence to diagnose genital or urinary infections, guides antibiotic therapy, and evaluates patients with discomfort, aiming to resolve infection.
Test Parameters: U. urealyticum presence
Pretest Condition: Fresh swab or urine sample required. Collect urine or vaginal swab. Report history of sexual activity.
Specimen: Urine (sterile container, 5-20 mL), Vaginal Swab (sterile swab/transport medium, 1-2 swabs); Swab or 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not recommended
Medical History: Document genital discomfort or infertility. Include current medications or sexual history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., infertility), and sample collection risks.
Procedural Considerations: Uses culture/PCR to detect bacteria, requiring labs with incubators or thermal cyclers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample delay or contamination can affect results. Antibiotics may alter detection, requiring correlation.
Clinical Significance: Positive result confirms infection, guiding therapy. Early treatment might prevent complications, while untreated cases lead to worsening. Negative results may require other tests.
Specialist Consultation: Consult a urologist or infectious disease specialist for interpretation.
Additional Supporting Tests: Urine culture, PCR, or STI panel to confirm diagnosis.
Test Limitations: Specific to U. urealyticum; correlation with symptoms needed. False negatives possible with low bacterial load.
References: CDC Guidelines, 2023; Journal of Bacteriology, Shepard MC, 2022.
